• FOLLOW US
Video Player
  • Email
  • share

PTC Therapeutics CFO: Positive News on Translarna Just the Start

PTC Therapeutics received a positive opinion from a European regulator in May for its Duchenne muscular dystrophy (DMD) treatment Translarna and conditional approval in Europe is expected this summer, said the company's CFO Shane Kovacs. Kovacs said

http://www.wltx.com/video/3693303075001/1/PTC-Therapeutics-CFO-Positive-News-on-Translarna-Just-the-Start http://cdn.newslook.com/13/138e3341bbfabfe0f21dc23ff0819586/images/frame_ext.jpg PTC Therapeutics CFO: Positive News on Translarna Just the Start PTC Therapeutics received a positive opinion from a European regulator in May for its Duchenne muscular dystrophy (DMD) treatment Translarna and conditional approval in Europe is expected this summer, said the company's CFO Shane Kovacs. Kovacs said FinanceyoutubeYahoo!newslookEurope 03:13

Next Up

    

More Videos

Recent Videos

Page 1 of 7